Membranoproliferative glomerulonephritis type II (dense deposit disease): An update

Gerald B. Appel, H. Terence Cook, Gregory Hageman, J. Charles Jennette, Michael Kashgarian, Michael Kirschfink, John D. Lambris, Lynne Lanning, Hans U. Lutz, Seppo Meri, Noel R. Rose, David J. Salant, Sanjeev Sethi, Richard J.H. Smith, William Smoyer, Hope F. Tully, Sean P. Tully, Patrick Walker, Michael Welsh, Reinhard WürznerPeter F. Zipfel

Research output: Contribution to journalArticle

289 Scopus citations

Abstract

Membranoproliferative glomerulonephritis type II (MPGN II) is a rare disease characterized by the deposition of abnormal electron-dense material within the glomerular basement membrane of the kidney and often within Bruch's membrane in the eye. The diagnosis is made in most patients between the ages of 5 and 15 yr, and within 10 yr, approximately half progress to end-stage renal disease, occasionally with the late comorbidity of visual impairment. The pathophysiologic basis of MPGN II is associated with the uncontrolled systemic activation of the alternative pathway (AP) of the complement cascade. In most patients, loss of complement regulation is caused by C3 nephritic factor, an autoantibody directed against the C3 convertase of the AP, but in some patients, mutations in the factor H gene have been identified. For the latter patients, plasma replacement therapy prevents renal failure, but for the majority of patients, there is no proven effective treatment. The disease recurs in virtually all renal allografts, and a high percentage of these ultimately fail. The development of molecular diagnostic tools and new therapies directed at controlling the AP of the complement cascade either locally in the kidney or at the systemic level may lead to effective treatments for MPGN II.

Original languageEnglish (US)
Pages (from-to)1392-1403
Number of pages12
JournalJournal of the American Society of Nephrology
Volume16
Issue number5
DOIs
StatePublished - Dec 9 2005

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Membranoproliferative glomerulonephritis type II (dense deposit disease): An update'. Together they form a unique fingerprint.

  • Cite this

    Appel, G. B., Cook, H. T., Hageman, G., Jennette, J. C., Kashgarian, M., Kirschfink, M., Lambris, J. D., Lanning, L., Lutz, H. U., Meri, S., Rose, N. R., Salant, D. J., Sethi, S., Smith, R. J. H., Smoyer, W., Tully, H. F., Tully, S. P., Walker, P., Welsh, M., ... Zipfel, P. F. (2005). Membranoproliferative glomerulonephritis type II (dense deposit disease): An update. Journal of the American Society of Nephrology, 16(5), 1392-1403. https://doi.org/10.1681/ASN.2005010078